Drug for deadly prostate cancer
British researchers have made a dramatic breakthrough against a lethal form of prostate cancer.
Trials of a new pill have shown that it can shrink tumours in up to 80 per cent of cases, and end the need for damaging chemotherapy and radiotherapy.
The drug works by blocking the hormones which fuel the cancer.
The Institute of Cancer Research hopes a simple pill form will be available in two to three years.
An advanced clinical trial involving 1,200 patients around the world is currently under way, with more trials likely later this year.
Prostate cancer is the most common cancer among men.
It is estimated that up to 10,000 men a year in the UK are diagnosed with the most aggressive - and almost always lethal - form of prostate cancer.